retatrutide vs semaglutide vs tirzepatide & Semaglutide. Tirzepatide. Retatrutide. Same goal

These are reported percentages from clinical trials

The most common adverse events are gastrointestinal: nausea (occurring in 12-33% of subjects depending on dose), diarrhea, constipation, and decreased appetite

Emerging evidence has also suggested similar benefits in epicardial fat [67]

HPLC-purified for high analytical purity, it is suitable for investigating peptide-receptor activity and biochemical mechanisms

Semaglutide vs tirzepatide at 50 units Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GIP/GLP-1 agonist that also comes in compounded multi-dose vials

Consult your healthcare provider if you experience any serious side effects